Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03794882 · ClinicalTrials.gov registry record · Phase 4

Impact of Quadratus Lumborum Block on Recovery Profile After Ventral Hernia Repair

A Phase 4 study, sponsored by University of Wisconsin, Madison.

Terminated
Registry status
Phase 4
Development phase
14
Enrollment target

NCT03794882 is a Phase 4 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03794882, a Phase 4 study, was terminated before completion, sponsored by University of Wisconsin, Madison.

TERMINATED
Registry status
Phase 4
Development phase
14 participants
Enrollment target

Study Summary

Ventral hernia repair may be associated with significant postoperative pain. Pain is typically managed with intravenous (IV) and oral medications that come with their own risks, such as nausea, constipation, sedation, respiratory depression, increased bleeding, and/or kidney or liver dysfunction. The quadratus lumborum peripheral nerve block has been shown to produce anesthesia of the anterior abdominal wall in the T7 to L1 distribution. This study aims to evaluate if the addition of the quadratus lumborum peripheral nerve block (QLB) can improve pain scores, decrease the need for IV and oral pain medications, and/or speed the patients' return to normal activity.

Interventions

  • COMBINATION_PRODUCT Quadratus Lumborum Block
  • PROCEDURE Standard Medical Management

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2019-05-06
Est. Completion 2020-03-12
Phase Phase 4

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT03794882

The ClinicalTrials.gov registry entry for NCT03794882 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Quadratus Lumborum Block is the first listed.

NCT03794882 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03794882 about?

NCT03794882 is a clinical study titled "Impact of Quadratus Lumborum Block on Recovery Profile After Ventral Hernia Repair". Ventral hernia repair may be associated with significant postoperative pain. Pain is typically managed with intravenous (IV) and oral medications that come with their own risks, such as nausea, constipation, sedation, respiratory depression, increased bleeding, and/or kidney or liver dysfunction. Th...

What is the current status of trial NCT03794882?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2019-05-06. Estimated completion is 2020-03-12.

What interventions are being tested in trial NCT03794882?

The interventions under investigation include: Quadratus Lumborum Block (COMBINATION_PRODUCT), Standard Medical Management (PROCEDURE).

Who is sponsoring clinical trial NCT03794882?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.